Mersana Therapeutics (MRSN) Insider Trading & Ownership

$2.07

-0.04 (-1.90%)

(As of 01:58 PM ET)

Current Insider Ownership Percentage: 11.80%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 7
Amount Of Insider Selling (Last 12 Months): $255,427.80

Get MRSN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mersana Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MRSN Insider Buying and Selling by Quarter

Ad Stansberry Research

A Gold Storm Is Coming

Strange new catalyst for gold ($5,000 possible?) Many are wondering why so many countries are frantically buying gold right now. The truth is this is just the beginning of a much larger story. One that could send gold soaring to even bigger highs in the coming months. But the best way to cash in on gold’s upside might surprise you.

One firm says this $6 stock could be the best way to get started.

Mersana Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/3/2024	Alejandra Carvajal	SVP	Sell	5,598	$1.96	$10,972.08
10/2/2024	Ashish Mandelia	CAO	Sell	4,855	$2.00	$9,710.00
10/2/2024	Brian Deschuytner	CFO	Sell	8,089	$2.00	$16,178.00
9/12/2024	Martin H Jr. Huber	CEO	Sell	50,423	$1.76	$88,744.48
1/16/2024	Anna Protopapas	Director	Sell	29,399	$2.71	$79,671.29
1/16/2024	Ashish Mandelia	CAO	Sell	5,025	$2.71	$13,617.75
1/16/2024	Brian Deschuytner	CFO	Sell	9,327	$2.71	$25,276.17
1/16/2024	Tushar Misra	SVP	Sell	3,357	$2.71	$9,097.47
10/26/2023	Mohan Bala	SVP	Sell	1,912	$1.13	$2,160.56

(Data available from 1/1/2013 forward)

MRSN Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Mersana Therapeutics includes Alejandra Carvajal, Andrew A F Hack, Anna Protopapas, Arvin Yang, Ashish Mandelia, Brian Deschuytner, Martin H Jr. Huber, Mohan Bala, Timothy B Lowinger, and Tushar Misra. Learn more on insiders at MRSN.
: 11.80% of Mersana Therapeutics stock is owned by insiders. Learn more on MRSN's insider holdings.
: The following insiders have sold MRSN shares in the last 24 months: Alejandra Carvajal ($26,314.24), Anna Protopapas ($179,237.33), Arvin Yang ($12,679.66), Ashish Mandelia ($43,848.25), Brian Deschuytner ($70,906.11), Martin H Jr. Huber ($88,744.48), Mohan Bala ($2,160.56), and Tushar Misra ($13,977.83).
: Insiders have sold a total of 152,556 Mersana Therapeutics shares in the last 24 months for a total of $437,868.46 sold.